Olimab 60mg injection
                     Olimab 60mg injection 
(Denosumab) - MHP
MILLION HEALTH PHARMACEUTICALS
olimab 60mg , olimab 60mg injection , olimab
 60mg price in India
DESCRIPTION
Olimab 60mg is a human monoclonal 
antibody for the treatment of 
osteoporosis, treatment-persuaded bone 
loss, metastases to bone, and giant cell 
tumor of bone. 
Olimab 60mg injection is contraindicated 
in people with low blood calcium levels.
Olimab 60mg is prescription drug which 
is used under the guidance of medical 
oncologist.
INDICATION
• Olimab 60mg injection Indicated for treatment 
ofosteoporosis at high risk postmenopausal 
women with (end of menopause/ change of life), 
whose have serious problem of fractures raised or 
who failed to other medication of osteoporosis.
• Olimab 60mg  Indicated for treatment of Breast 
cancer in women whose taking certain treatment 
which make severe their risk of fractures and 
bone loss in men with prostate cancer.
• Indicated for treatment in adults and some 
adolescents with giant cell tumor of bone which 
cannot treat with surgery / surgery is not possible 
is treated with Olimab 60mg injection.

MECHANISM OF ACTION
Denosumab (Olimab 60mg 
)mechanism by aiming a protein called 
RANKL, which is required for new 
osteoclasts to be made and to 
function. This promote to inhibit 
further breakdown of bone and 
reduces the risk of problems caused by 
secondary bone cancer, such as 
fractures. It can also promote to 
decreased pain caused by secondary 
bone cancer.
PRODUCT DETAILS
Brand :Olimab
Ingredients : Denosumab
Strength : 60mg
Manufactured : Intas 
Pharmaceuticals
Package : 1 injection in a prefilled 
syringe
Price : olimab 60mg price in India
olimab 60mg
ADME
• Peak plasma concentration: 
6.75mcg/mL
• Tmax: 10days
• Without aggregation in Olimab 60mg 
pharmacokinetics with duration was 
noticed upon multiple dosing of 60 mg 
SC administered once every 6 months.
• Pharmacokinetics of Olimab
 60mg injection will not affected by the 
binding antibodies formation.
• Half-life is 25.4 days.
DOSAGE MANAGEMENT
For adult :
The prescribed dose for Osteoporosis is olimab 60mg SC 
(subcutaneously) once every 6 months
The prescribed dose for Androgen Deprivation induced 
bone loss is olimab 60mg injection SC q6months.
The prescribed dose is Glucocorticoid induced 
osteoporosis olimab 60mg SC q6months.
The prescribed dose is Aromatase inhibitor induced bone 
loss olimab 60mg injection SC q6months
For pediatric :
The prescribed dose is 13 years and older and 45kg or 
more for Giant Cell Tumor of bone: The recommended 
dose is of 120mg Olimab 60mg tablet given SC, with 
additional 120mg doses on days 8 and 15 of the 1st 
month treatmentevery 4 weeks.
OVERDOSE
No experienced with Olimab
 60mg injection overdose. If 
occurs take the patient to 
emergency department and call 
poison control
PRECAUTIONS
• Before starting denosumab should be corrected. 
Hypocalcemia may worsen, specifically in 
patients with renal impairment. Sufficiently 
supplement patients with calcium and vitamin D.
• Olimab 60mg injection has negative effects of 
immuno-suppressantsmay improve. Especially 
the harm for severe infections may be raised. 
Discuss with your doctor of any immuno-
suppressive drugs you early consume.
• While treatment with Olimab have 
Osteonecrosis of the jaw (ONJ) has been reported 
with denosumab – check for symptoms.
SIDE EFFECTS
Common side effects for the 
patient taking Olimab
 60mg injection :
• Nausea
• Fatigue
• Muscle weakness
• Hypophosphatemia.
SIDE EFFECTS
Less common side effects for patients taking Olimab
 60mg :
• Diarrhae
• Shortness of breath
• Hypocalcemia
• Joint pain
• Hypocalcemia
• Cough
• Arthralgia
• Limb pain
• Eczema
• Headache
• Eczema
• Rash
DRUG INTERACTION
No formal drug-drug interaction with 
denosumab (Olimab 60mg) during trials.
When concomitant use with some 
anticancer drug, orthopedic drugs, vaccines 
will lead to risk of adverse effects can be 
increased
CONTRAINDICATION:
Olimab 60mg injection is contraindicated in
Hypocalcemia
Pregnancy
Hypersensitivity
PREGNANCY
category C
The Olimab 60mg which has no enough data in 
pregnant women to convey any drug analog risk 
for adverse development outcomes the drug in 
pregnant women is contraindicated for use 
because it may cause serious risk to the fetus.
LACTATION:
Olimab 60mg injection is excreted into human 
milk is not known. Since possible for severe side 
effects occurs in nursing infants from Olimab
 60mg injection. Avoid breastfeeding during 
treatment of Denosumab.
STORAGE
Store at 2°C to 8°C in the original container.
Avoid freeze.
Before to administration keep at room temperature.
Olimab 60mg protect from direct light and heat.
MISSED DOSE:
If Olimab 60mg dose is missed then have the dose 
immediately before next dose duration. Next dose 
time reaches then left off the missed dose and 
follows regular schedule. Avoid taking double dose 
at same time.
Please consult the doctor for further information.
CONTACT US
PHONE NO : +91-9940472902
EMAIL ID [email protected]
WEBSITE URL 
    https://millionpharma.com/olimab-60mg.php
KEYWORDS 
olimab 60mg , olimab 60m injection , olimab
 60mg price in     
india